Sort
25,944 grants matching “neurodegeneration”
Spatio-temporal control of FOXO3
$251,250Robert G Kalb · Children'S Hosp Of Philadelphia · R21 · FY2012 · AG
Variations in nursing home residents' depression by level of cognitive impairment
$251,250Christine Marie Ulbricht · Univ Of Massachusetts Med Sch Worcester · R21 · FY2017 · AG
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimerâs disease
$251,250Luca Giliberto · Feinstein Institute For Medical Research · R21 · FY2021 · AG
Identification of blood-brain-barrier pericyte-specific cis regulatory elements
$251,250Nathan D Lawson · Univ Of Massachusetts Med Sch Worcester · R21 · FY2018 · NS
Identifying kinase signaling pathways linked to tau-mediated neurodegeneration
$251,250Todd Jonathan Cohen · Univ Of North Carolina Chapel Hill · R21 · FY2023 · AG
Investigating Dysfunction of Neuroimmune-Related Processes in Models of ALS/FTD TDP-43
$251,250Daryl A Bosco · Univ Of Massachusetts Med Sch Worcester · R21 · FY2025 · NS
The functions of the zinc finger protein ZPR1 in R-loop metabolism and neurodegeneration.
$251,195Laxman Dass Gangwani · Texas Tech University Health Sciences Center At El Paso · R01 · FY2022 · NS
TIP60 and APP in Neuronal Development
$251,188Felice Elefant · Drexel University · R01 · FY2010 · HD
Neuroprotective and Antiviral Effects of BMD-101 and BMD-104 in HIV Infection
$251,163Joseph P Steiner · Biomedisyn Corporation · R41 · FY2010 · MH
CYTOKINES, NEURODEGENERATION AND DOWN'S SYNDROME
$251,100University Of Arkansas Med Scis Ltl Rock · R01 · FY2000 · HD
Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease
$251,085Albert R La Spada · Duke University · R01 · FY2017 · EY
PERK determines polarized targeting of growth factors in neurons
$250,948Tali Gidalevitz · Drexel University · R21 · FY2021 · AG
Outreach, Recruitment and Engagement Core
$250,894Sophia Wang · Indiana University Indianapolis · P30 · FY2025 · AG
Probing Neurodegeneration with Drosophila
$250,880Juan Botas · Baylor College Of Medicine · R01 · FY2009 · NS
CORE A: Administrative Core
$250,770Jessica Kirkland Caldwell · Cleveland Clinic Foundation · P20 · FY2025 · GM
Identifying the neuronal substrates of the depalmitoylating enzyme PPT1
$250,750Sreeganga S Chandra · Yale University · R21 · FY2016 · NS
The neurobiology of 12/15 lipoxygenase
$250,736Domenico Pratico · University Of Pennsylvania · R01 · FY2006 · AG
The structural basis of apoE4's role in Alzheimer's Disease
$250,700John Carl Voss · University Of California At Davis · R01 · FY2010 · AG
INTEGRINS: LINKING SENILE PLAQUES AND NEURITIC DYSTROPHY
$250,663Adriana B Ferreira · Northwestern University At Chicago · R01 · FY2007 · NS
Disorders of Copper Transport
$250,641Stephen Kaler · Child Health And Human Development · Z01 · FY2007 · HD
A new PET neuroimaging probe for sigma 1 receptor
$250,640Changning Wang · Massachusetts General Hospital · R03 · FY2021 · DA
CORE--NEUROPATHOLOGY CORE
$250,626Andrew P Lieberman · University Of Michigan At Ann Arbor · P50 · FY2008 · AG
Develop an ANS-based Personalized Cognitive Training for Mild Cognitive Impairment
$250,607Feng Vankee Lin · Stanford University · R21 · FY2021 · AG
DETERMINANTS AND CONSEQUENCES OF MDMA NEUROTOXICITY
$250,580University Of Cincinnati · R01 · FY2002 · DA
Developing a validated biomarker of cortical neurodegeneration in Alzheimer's disease using high-gradient diffusion MRI
$250,500Susie Yi Huang · Massachusetts General Hospital · R21 · FY2024 · AG